110
Participants
Start Date
January 16, 2020
Primary Completion Date
February 11, 2021
Study Completion Date
March 10, 2021
AKST4290
Oral AKST4290
Placebo
Oral Placebo
Atlanta Center for Medical Research, Atlanta
Henry Ford Hospital West Bloomfield, West Bloomfield
Movement Disorder Clinic of Oklahoma PLLC, Tulsa
AS Ida-Tallinna Keskhaigla / East Tallinn Central Hospital, Tallinn
Astra Kliinik / Astra Team Clinic, Tallinn
Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden
Krankenhaus Agatharied GmbH, Hausham
Paracelsus-Elena-Klinik Kassel, Kassel
Universitatsklinikum Leipzig, Leipzig
UKGM Marburg, Marburg
Klinikum rechts der Isar der Technischen Universität München, München
Universitätsklinikum Tübingen, Tübingen
Universitätsklinikum Ulm, Ulm
Centrum Medyczne PRATIA/ Medical Center PRATIA, Częstochowa
Krakowska Akademia Neurologii/ Cracow Academy of Neurology, Krakow
Instytut Zdrowia Dr Boczarska-Jedynak Spolka Z Oraganiczona Odpowiedzialnoscia Spolka Komandytowa/ Institute of Health dr Boczarska-Jedynak, Oświęcim
Medicome SP. ZO. O./ Medicome, Oświęcim
Neurologiczny Nzoz Centrum Leczenia Sm Osrodek Badan Klinicznych, Plewiska
Euro-Neuro, s.r.o., Neurologická ambulancia, Bratislava
Nemocnica Kramáre II. Neurologická klinika LF UK a UNB /2nd Dept. Of Neurology, Comenius University Faculty of Medicine and University Hospital Bratislava, Bratislava
Nemocnica s poliklinikou Sv. Lukáša Galanta, a. s Neurologické oddelenie /Neurology Dpt., NsP Galanta, Galanta
Univerzitná nemocnica Martin Neurologická klinika/University hospital Martin, Clinic of Neurology, Martin
Lead Sponsor
Alkahest, Inc.
INDUSTRY